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The aim of this study was to evaluate the effect of ethanol and
morphine on nociceptive behavioral responses evoked by the
injection of formalin into the temporomandibular joint region of
rats (the TMJ formalin test). In experiment 1, animals were given
an ethanol solution (6.5%) or tap water to drink for 4 and 10
days, before the procedure for TMJ pain. In the group treated for
4 days, significant analgesia was observed in the TMJ formalin
test, whereas the group treated for 10 days did not show this effect,
revealing the development of tolerance to ethanol antinociceptive
effects. In experiment 2, animals were submitted to chronic regimen
of ethanol (6.5% for 10 days) and the control group was given tap
water to drink. After this period, morphine (10 mg/kg i.p.) was
administrated 30 minutes before the TMJ formalin test. Morphine
had the same analgesic effect in both groups, showing that the
treatment with ethanol was not able to alter the analgesic potency
of morphine. The results showed that ethanol can affect nociceptive
behavioral responses related to pain from deep tissues, like the
TMJ, and the absence of interaction between ethanol and morphine
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Ethanol and opioids interfere diferentially with
transmission processes in the central nervous system
(CNS), affecting many of the known neurotransmitter
systems (Vasconcelos et al., 2003). Morphine, the main
effective substance in opium, has been used as a potent
analgesic in clinical practice and is still the primary
analgesic for severe pain. Unfortunately, opioids have
adverse side effects, including constipation, nausea and
respiratory depression, which limit their use. Moreover, the
users readily develop tolerance and dependence to opioids
(Ikeda et al., 2002).
Ethanol affects many functions of the CNS, resulting
in analgesia, sedation, hypnosis, motor disturbance,
memory disturbance, confusion, neurodegeneration, and/
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or dependence (Deitrich et al., 1989; Fadda, Rossetti,
1998). Ethanol-induced analgesia has been reported in both
humans (Cutter, O´Farrel, 1987; Woodrow, Eltherington,
1988) and animals (Bass et al., 1978; Brick et al., 1976;
Pohorecky, Shah, 1987; Yirmiya, Taylor, 1989). Previous
research evaluated nociception using typical cutaneous
pain models such as tail-flick (Jorgensen, Hole, 1981) and
foot-shock (Friedman et al., 1980). Our study shows the
effects of ethanol and morphine on pain response evoked
by deep stimuli, different from the one evoked by superfi-
cial stimuli. A particular feature of deep pain conditions is
the considerable convergence of cutaneous, visceral,
muscle, or joint afferents of spinal as well as trigeminal
somatosensory neurons transmitting deep nociceptive
information (Sessle, Hu, 1991). Moreover, studies in
animals models of persistent pain at spinal levels indicate
that peripheral tissue or nerve injury induces a state of
hyperexcitability that participates in the development of
persistent pain and hyperalgesia (Dubner, 1991; Woolf
1983). In relation to the orofacial region, Iwata et al. (1999)
demonstrated that TMJ inflammation resulted in more
robust changes in medullary dorsal horn nociceptive
neurons as compared with perioral inflammation. Thus,
considering that the nociceptive behavioral responses
elicited by the injection of formalin into the TMJ represent
a valid and reliable model of deep orofacial pain (Roveroni
et al., 2001), the purpose of this study was to evaluate the
effect of ethanol and morphine on the pain responses
induced by TMJ formalin test. Information on the extent of
ethanol-induced changes in nociceptive systems can be of
clinical value, especially in individuals who regularly drink
alcohol and suffer from some kind of chronic pain
conditions, like temporomandibular disorders.
MATERIAL AND METHODS
Animals
Male Wistar rats (obtained from Centro Multi-
institucional de Bioterismo-Cemib, Unicamp, Campinas,
Brazil) weighing 200-300 g served as subjects. The rats
were housed individually and maintained on a 12L:12 D
cycle (light onset at 07:00 h) in a temperature-controlled
room (23 ± 1 oC). The study was conducted in accordance
with the ethical guidelines for investigations of experimen-
tal pain in conscious animals (Zimmermann, 1983).
Procedure: Ethanol administration
Rats (N=6/group) were given either an ethanol
solution, as their sole drinking solution, or tap water for 4 or
10 days (according to experiments). The ethanol drinking
solution was mixed to a 6.5% concentration using 99.5%
ethanol and tap water (Gatch, Lal, 1999; Bell et al., 1998).
Pretreatment was carried out in the animals´ home cages.
On day 4, one group was taken from the vivarium to the test
room and submitted to the TMJ formalin test. In another
group, the nociception assay was accomplished 10 days after
ethanol or water consumption (control group) to evaluate the
development of tolerance to antinociceptive effects of
chronic ethanol. Blood ethanol concentrations remain
elevated throughout chronic administration when this
concentration of ethanol solution is used (Shah et al., 1997).
Morphine test
Animals were submitted to chronic regimem of
ethanol (6.5% for 10 days) and the control group was
given tap water to drink. After this period, morphine
10 mg/kg (Bell et al., 1998) was injected IP 30 minutes
before the procedure for TMJ pain.
Testing procedure for TMJ pain
The design of this study follows the design used by
Roveroni et al. (2001). Testing sessions took place
between 08:00 and 13:00 h in a quiet room mantained at 23
± 1 oC. Each animal was first placed in a test chamber (30
X 30 X 30 cm mirrored-wood chamber with glass at the
front side) for a 30 min habituation period to minimize
stress (Abbott et al., 1986). After the period of adaptation,
the animal was removed from the test chamber and lightly
anesthetized by inhalation of halothane to allow the TMJ
injection.
Rats received a 50 µL injection of diluted formalin
(1,5 %) into the left TMJ region. The injections were
performed via a 30-gauge needle introduced into the TMJ
capsule. A cannula consisting of a polyethylene tube was
connected to the needle and also to a Hamilton syringe
(50 µL) previously filled with formalin 1.5%. The lower
border of the zigomatic arch was palpated and the needle
was introduced in direction to the lateral region of condyle
(Figure 1).
Following the TMJ injection, the rat immediately
recovered from the anesthesia and was returned to the test
chamber for a 45 min observation period (15 blocks of
3 min). For each block of 3 min, the behavior characterized
by rubbing the orofacial region was quantified by the
amount of time that the animal exhibited it and the behavior
characterized by flinching the head was quantified by its
occurrence (number of head flinches). Considering that the
flinching of the head behavior followed a uniform pattern
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of 1 s in duration, each flinching was expressed as 1 s. The
combination (sum) of both behaviors provides a better
measure of pain intensity than any single behavior
(Roveroni et al., 2001). An investigator who was blind to
the rat´s group assignment made the analysis of the
behaviors.
After the conclusion of each experiment, Evans blue
dye (1%, 5 mg/kg) was injected systemically in order to
confirm the TMJ injection site at post-mortem, as
previously described (Haas et al., 1992) by the visual
examination of formalin-induced plasma extravasation of
Evans blue dye bond to plasma protein.
Drugs
Ethanol (99.5%) was mixed with water for a
concentration of 6.5% (v/v). Morphine sulfate was
dissolved in isotonic saline and delivered in a volume of
1 mL/100 g of body weight. Evans blue dye was dissolved
in isotonic saline for a concentration of 1%. All drugs were
obtained from Sigma, São Paulo, Brazil.
Data Analysis
The sum of rubbing and flinching responses
exhibited by each animal was computed. Parametric tests
[t-test and ANOVA (analysis of variance)] were employed,
as appropriate. All values are given as mean ± standard
deviation (SD). A level of 5% was taken as evidence of
statistical significance. Body weight, water and ethanol
consumption were analyzed by repeated measures
ANOVA and polynomial regression. Data were analyzed
using SAS (version 8.2 for windows) by Institute Inc., Cary,
NC, USA-licensed to Universidade Estadual de Campinas.
RESULTS
Body Weight and Fluid Consumption
Figure 2 presents body weight and fluid consumption
over the course of 4– day access to 6.5 % ethanol.
Although there was a significant increase in body weight
over days [F=18.06, p<0,0001 (Figure 2A)], there was no
effect of ethanol treatment on body weight (F=0.01,
p=0.9095) and no significant interaction between days and
treatment (F=1.73, p=0.1825). There was no effect of
ethanol treatment on fluid consumption (F=2.29, p=0.1613)
and no significant interaction between days and treatment
[F=0.11, p=0.9562 (Figure 2B)].
Figure 3 presents body weight and fluid consumption
over the course of 10–day access to 6.5 % ethanol.
Although there was a significant increase in body weight
over days [F=79.06, p<0,0001 (Figure 3A)] there was no
effect of ethanol treatment on body weight (F=0,
p=0.9533) and no significant interaction between days and
treatment (F=0.86, p=0.5633). There was no effect of
ethanol treatment on fluid consumption (F=0.59, p=04585)
FIGURE 1 - Punction local for formalin administration.
FIGURE 2 - The effect of ethanol drinking on body weight and fluid consumption. Rats had forced access (24 h/day)
to water or ethanol (6.5 % v/v) for 4 days. A - mean ± SD daily body weight (N=6/group). B - the amount of water and
ethanol consumption per day is presented as mL/day.
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and no significant interaction between days and treatment
[F=0.21, p=0.9930(Figure 3B)].
Effects of Chronic Ethanol Administration
The antinociceptive effects of ethanol (6.5% in drink
solutions) were apparent by the fourth day of exposure to
ethanol solution. The reduction of pain responses was
statistically significant (p< 0.001, t-test; Figure 4) when the
control group (219.48 ± 40.148) was compared with the
experimental group (122.36 ± 45.48).
By day 10, the sum of nociceptive behaviors in the
TMJ formalin test was not significantly different between
control X test group, revealing that tolerance to the
antinociceptive effects of ethanol has been developed
(p=0.98, t-test, Figure 4). The values of control group
(171,07 ± 39,35) were comparable with the test group
(170,71± 43,15; Figure 5).
Morphine test
Analysis of simple main effects of baseline behavior
(formalin) vs. postdrug behavior (formalin + morphine)
revealed that morphine produced significant analgesia in
both groups [water pretreatment: baseline (171.07 ± 39.24)
vs. postdrug (13.96 ± 19.68); ethanol pretreatment: baseline
(170.71 ± 43.146) vs. postdrug (14.29 ±10.79) – p<0.001
Oneway ANOVA + Tukey, Figure 6]. No significant
differences were found between postmorphine behaviors,
indicating that the rats did not develop cross-tolerance
FIGURE 3 - The effect of ethanol drinking on body weight and fluid consumption. Rats had forced access (24 h/day)
to water or ethanol (6.5 % v/v) for 10 days. A - mean ± SD daily body weight (N=6/group). B - the amount of water
and ethanol consumption per day is presented as mL/day.
FIGURE 4 - Sum of nociceptive behaviors in the TMJ
formalin test after 4 days of drinking an ethanol solution
(N=6) or water (N=6). Each column represents the mean.
Errors bars indicate the SD. Single asterisk indicates
significant difference between the experimental and water
control group (p< 0.001, t-test).
FIGURE 5 - Sum of nociceptive behaviors in the TMJ
formalin test after 10 days of drinking an ethanol solution
(N=6) or water (N=6). Each column represents the mean.
Errors bars indicate the SD. No significant differences
were found in pain responses for animals pretreated with
ethanol vs. water (p=0.98, t-test).
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between ethanol-induced analgesia (EIA) and morphine-
induced analgesia (MIA).
DISCUSSION
Alteration in the perception of pain can be produced
by either environmental or pharmacological manipulations.
In an early study, ethanol was found to attenuate naloxone-
induced hyperalgesia (Bass et al., 1978), suggesting a
possible interaction between EIA and the endogenous
opioid systems. Ethanol-opiate interactions have also been
addressed by examining cross-tolerance between EIA and
MIA. Jorgensen and Hole (1984) found that neither
tolerance to EIA nor cross-tolerance to MIA developed in
rats injected with 2.5 g/kg ethanol for 8 days. However,
tolerance to EIA accompanied by cross-tolerance to MIA
was found if the animal were exposed to the analgesic test
(i.e., tail-flick) during tolerance induction (Jorgensen et al.,
1986). This tolerance is called “associative” or
“environment-dependent” tolerance. Although some
studies have shown that tolerance to ethanol’s effects can
be reduced or eliminated if animals are tested in an
environment that is different from that which was used to
induce tolerance (Jorgensen, Hole, 1984; Gatch, Lal, 1999;
Jorgensen et al., 1986), Bell et al. (1998) showed that
tolerance to antinociceptive effect of ethanol can be
induced in rats using both non-associative (self-
administration) and associative (IP injections) paradigms.
They also support that EIA was nonopioid in nature, as
neither form of ethanol tolerance was accompanied by
cross-tolerance to MIA. Inversely, Shah et al. (1997)
demonstrated that ethanol consumption decreases the
analgesic potency of opioids in mice through a mechanism
that is unrelated to pharmacokinetics or opioid receptor
changes in brain and cord. The study of Duttaroy et al.
(1998) showed that chronic forced ethanol drinking can
decrease the analgesic potency of opioid agonists in mice,
and this effect may be produced via alterations in G-
protein-coupled intracellular mechanisms. The reason for
these discrepancies should be related to a number of
factors including species-related differences (Boada et al.,
1981; Fidecka et al., 1986; Jorgensen, Hole, 1981), and the
test used to measure opiate-ethanol interactions (Khanna,
Lê, 1996). Our data show that tolerance to EIA was
induced by pharmacological rather than behavioral factors,
because the tolerance induction procedure was carried out
in the rat’s cages and the TMJ formalin test in another
room, after a habituation period to minimize stress (Abbott
et al., 1986). Furthermore, the results of this study do not
support an ethanol-opiate interaction for EIA, as ethanol
tolerance was not accompanied by cross-tolerance to
MIA, indicating that ethanol’s analgesic effects on TMJ
formalin test is mediated by nonopiate mechanisms.
The mechanism though which ethanol produces
antinociception is not clear; in fact, more than one
mechanism could be involved. Ethanol has NMDA
antagonist properties as supported by electrophysiological
(Lovinger et al., 1989), biochemical (Hoffman et al.,
1989), and behavioral studies (Kosten, Bombace, 2001).
Grant (1999) reported that ethanol can also act as positive
modulator of GABAA receptors, enhancing GABA-
activated flow of Cl-; lower training doses of ethanol can
enhance the 5HT-effect on 5HT1B/2c receptors, which
are situated basically in inhibitory interneurones. Gruss et
FIGURE 6 - Analgesic effect of morphine (10 mg/kg, IP) in the TMJ formalin test after ten days of drinking an ethanol
solution (N=6) or tap water (N=6). Data are expressed as the mean of the sum of nociceptive behaviors SD. * indicates
significant differences from baseline (formalin) nociceptive behaviors.
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al. (2001) suggested that the activation of large-
conductance calcium-activated K+ channels (BK (Ca)
channels) induced by clinically relevant concentrations of
ethanol might contribute to ethanol-induced analgesia.
Ethanol inhibits current responses mediated by ATP recep-
tor channels designated as P2X receptors (Li et al., 1994;
Weight et al., 1994). Among the various targets of ethanol,
G protein-activated inwardly rectifying potassium (GIRK)
channels are the only molecules whose involvement in
ethanol-induced analgesia has been demonstrated in vivo
(Ikeda et al., 2001).
Since most of the molecules mediating ethanol
effects are the same associated with the modulation of
pain arising from deep tissues, for example, GABAA-R
(Kenji et al., 2001), GIRK (Ikeda et al., 2001), NMDA
receptors (Yu et al., 1996), 5HT-receptors (Garraway,
Hochman, 2001) and ATP-R (Hu et al., 2002), its possible
that ethanol can influence nociceptive mechanisms related
to deep tissue injuries, which have characteristics different
from those related to cutaneous injuries (Sessle, Hu, 1991).
In the present study, we also used systemic morphine
administration to evaluate the interaction between ethanol
and opioids on the pain perception evoked by TMJ formalin
test. Morphine significantly reduced the formalin-induced
rubbing and flinching responses at a concentration of
10 mg/kg, the same used in the study of Bell et al. (1998).
The analgesic potency of morphine was the same in animals
pretreated either with water or ethanol, revealing that
ethanol was not able to decrease the effectiveness of
morphine. The absence of cross-tolerance between EIA and
MIA suggest that the mechanisms of ethanol’s analgesic
effects are nonopiate in nature on the TMJ formalin test.
The formalin test (Roveroni et al., 2001; Dubuisson,
Dennis, 1977) is a commonly used model of tonic and
inflammatory pain. Because it models naturally-occuring
painful stimuli, it is more relevant to clinical pain and more
sensitive to the effects of analgesic drugs than phasic pain
models such as the hot-plate or tail-flick (Hammond, 1989).
One of the characteristics of the formalin response is its
biphasic pattern (Abbott et al., 1995; Clavelou et al., 1995).
Whilst the first phase formalin response is mediated by direct
afferent stimulation, the second phase behavioral response is
dependant on a central hyperexcitability of the recipient
second-order dorsal horn neurons (Martindale et al., 2001).
Thus, considering that the TMJ formalin test evaluate the later
response (Roveroni et al., 2001), we suggest that ethanol’s
effects on this test are centrally-mediated.
In conclusion, our results show that ethanol can
affect nociceptive behavioral responses related to pain
from deep tissues, like the TMJ, and the absence of
interaction between ethanol and morphine suggest that
ethanol’s analgesic effect on the TMJ formalin test is
mediated by nonopiate mechanisms.
RESUMO
A influência do etanol e da morfina sobre a per-
cepção dolorosa provocada por injúria tecidual
profunda
O objetivo deste estudo foi avaliar o efeito do etanol e
da morfina sobre as respostas comportamentais
nociceptivas provocadas pelo teste da formalina na
ATM de ratos (Teste da formalina na ATM). No experi-
mento 1, os animais receberam uma solução de etanol
6,5 % ou água comum para beber durante 4 e 10 dias,
antes da realização do teste da formalina na ATM. No
grupo tratado por 4 dias, observou-se analgesia signi-
ficativa ao teste da formalina, enquanto que no grupo
tratado por 10 dias esse efeito não ocorreu, demons-
trando o desenvolvimento de tolerância aos efeitos
antinociceptivos do etanol. No experimento 2, os ani-
mais foram submetidos ao regime crônico de etanol
(6,5% por 10 dias) e o grupo controle recebeu água
comum para beber. Após esse período, foi administra-
do morfina (10 mg/kg i.p.) 30 minutos antes da realiza-
ção do teste da formalina na ATM. A morfina teve o
mesmo efeito analgésico nos 2 grupos, demonstrando
que o tratamento com etanol não foi capaz de alterar a
potência analgésica da morfina. Os resultados mostra-
ram que o etanol é capaz de alterar as respostas
nociceptivas relacionadas à dor proveniente de tecidos
profundos, como a ATM, e a ausência de interação entre
o etanol e a morfina indica que a analgesia induzida
pelo etanol é mediada por mecanismos não-opióides.
UNITERMOS: Etanol. Morfina. Teste da formalina.
Articulação temporomandibular.
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